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DESPITE the great effort on cancer research our progress towards an under-
standing of today's major medical problem continues to be disappointingly slow.
It seems beholden on all to try to offer helpful contributions on possible mechan-
isms of carcinogenesis in the hope that a true understanding will more rapidly
emerge. It is in this spirit that I suggest a mechanism for chemical carcinogenesis
which is simple in essence but appears to have been ignored.
Studies on cocarcinogenesis have established that the single application to
skin ofone chemical (the initiator) followed, after a suitable delay, by the repeated
application of another (the promoter) can induce papillomas and more rarely
carcinomas on the treated area. Neither the initiator nor the promoter need
necessarily be detectably carcinogenic when acting alone. In explanation of
these observations I propose that the initiator induces recessive mutations in
genes controlling division in epithelial cells and that the promoter leads to homo-
zygosity of the mutant genes and consequently to their expression. Let us
examine this proposal.
It is reasonable to assume that the regulation of growth, division and differ-
entiation of the mammalian cell is determined by its genetic complement; the
zygote must contain complete information to programme all cell divisions and
progression to the adult animal. We would expect this information to be coded in
DNA and can therefore presume that there are genes concerned with the regula-
tion of cell division. It is also reasonable to think that different genes exert
their control at different stages during development and that mutations could
result in altered gene products which no longer act correctly in regulating cell
division. At present we have no idea how such regulation is effected at the
molecular level in mammalian cells and are only now at the beginning of such
studies with bacteria. Essentially cancers are manifestations ofalterations ofthe
normal controls of cell division and, on the above assumptions, could result from
mutations of the relevant genes. That cancer cells differ genetically from their
progenitors seems beyond question; they retain their characteristics over many
cell generations, when transferred to new cellular environments as metastases and
when transplanted to new permissive hosts.
A first requirement of the proposal is that initiators must be mutagenic in
mammalian cells-are they? A problem here is that data concerning initiation
derives mainly from studies on mammalian (usually mouse) skin whereas that for
mutagenesis comes mainly from studiesonmicro-organisms. Thereisnot complete
correspondence of the two activities; however, the association between initiating
and mutagenic activities is high, although the reverse is by no means so-many
mutagens fail to act as initiators. Such mutagens may be metabolised or fail
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activity while having free access to their targets in microbial systems: they may
therefore not conflict with the proposal. The rarer examples of chemicals with
initiating but no demonstrable mutagenic action are of more concern but similar
excuses could be invoked to account for them. The generality nevertheless is
that initiators tend strongly to be mutagens as is required by the proposal.
It is not a prerequisite that cells must be in an actively dividing stage for
sensitivity to chemical mutagenesis, so that a single application ofthe mutagen in
adequate amount and at any time could suffice to induce the proposed mutations,
as is found to be effective for initiation in practice. The majority of newly
arising mutations in diploid cells are recessive to their wild-type alleles and
mutations restricted to specific genes are rare events. One would expect, there-
fore, that initiators applied to an area ofskin would, ifacting as proposed, generate
rare recessive mutant genes in cells composing the tissue; it is found that only a
small fraction of the population of cells treated with the initiator eventually
becomes cancerous. Simultaneous mutation of homologous gene pairs within a
single diploid cell with retention of cell viability would be extremely rare (the
product of the low separate probabilities) but, theoretically, would lead to
undelayed expression of the mutations. Here we should bear in mind, in consid-
ering carcinogenesis in general, the very large population ofcells forming the adult
mammal (c. 1014 in man) which permits the extreme rarity ofan event leading to a
progressive cancer still to have real significance to the individual.
Cells which have acquired a recessive mutation in a gene normally concerned
with control ofsome aspect ofcell division, could reasonably be expected to divide
at the rate normal for neighbouring cells composing the same tissue and so to
persist indefinitely as part of the cell population. A gene dosage effect may, in
fact, allow them to form an increasing proportion of this population with the
passage of time. While such cells remained heterozygous they would not be
extraordinary and would remain undetected; but should they become homo-
zygous for the recessive character and relieved ofthe control exertedby the normal
gene their unrestrained division might ensue to give a neoplasm. The production
of recessive mutations as the primary event in chemical carcinogenesis clearly
would explain the often long protracted time lag between the event andthe appear-
ance of the cancer. There are many ways in which homozygosity could be
achieved; some obvious ones are loss of the normal allele by deletion, or of the
chromosome carrying it through errors in mitosis such as non-disjunction of sister
chromatids, interference with centromere structure or with spindle function, and
by mitotic recombination. Natural examples of mis-divisions are seen in the
production oftrisomic individuals and ofpolyploid cells in plants and mammalian
embryos. I propose that promoting chemicals increase the frequency of mis-
division in some way to give homozygosity and consequent expression of the
recessive mutations induced by the initiator.
Ifthe promoter acts to cause errors during division one would expect its activity
to be restricted to cells which are in, or are about to enter into, division, or even
to those in a particular stage of the mitotic process, so that the observed require-
ment for the repeated application of the promoting substance would be under-
standable. The persistence ofpromoters applied to the skin may be short relative
to the generation time of normal skin cells and of those carrying the recessive
mutations ofimportance, so that to assure the coincidence ofaneffective concentra-
tion of promoter and of cells in a sensitive stage of mitosis would require repeated
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application ofthe promoter for long periods. High levels ofpromoter acting for a
short period would be less effective than lower, but adequate, levels acting for
longer as is observed.
Assuming that promoters act by interference with chromosome distribution
during cell division (which could be readily tested by experiment) the variety of
cell types resulting, with respect to the mutations postulated to have arisen from
the activity ofthe initiator, could be as follows:
1. Diploids with 2 normal chromosomes.
2. Aneuploids lacking the mutated chromosome.
3. Trisomics with 2 normal and 1 mutated chromosome.
4. Trisomics with 1 normal and 2 mutated chromosomes.
5. Diploids with 2 mutated chromosomes.
6. Aneuploids with 1 mutated chromosome.
Of these types, 1, 2 and 3 could be expected to retain normal control of cell
division, type 4 to be either normal or to show enhanced cell division, and types
5 and 6 to be uncontrolled. It is tempting to suggest that type 4 cells might
display the properties of benign tumour cells they would be capable of progres-
sion to the malignant state irreversibly with time, as frequently they are observed
to do. Type 5 cells when first arising would be truly minimally deviated and need
show no abnormality of karyotype. The complete loss of one chromosome would
permit the expression of all recessive alleles on its homologue and lead perhaps
to quantitative and qualitative alterations in the production of enzymes and other
cell components in the tumour cell. Detailed studies of these differences between
tumour and normal cells would largely fail to contribute to an understanding
of the basic mechanism leading to malignancy, although possibly of value in
identifying points at which tumour cells may be selectively attacked by chemo-
therapeutic agents.
In referring to " genes controlling cell division " no attempt has been made to
specify in what ways these may act they could do so by controlling enzymes
necessary for DNA synthesis, by controlling the transcription of genes whose
products function in normal cell division, or in determining structural components
of cell membranes, or any processes essential for the normal cell cycle. This
vagueness is unavoidable in our present state or ignorance ofthe control ofdivision
in normal cells. Of the possibilities stated, that concerning the specification of
membrane components has much appeal to me. It is a feature of malignant
cells that they lack the adhesive properties shown by cells which are normal for
the tissue in which they arise although, of course, not all non-adherent cells are
necessarily malignant. Unfortunately we do not know what are the adhesive
forces which retain normal tissue cells in their orderly association. It seems likely
that their membranes must be structured in a way that ensures the closest possible
molecular approach to identical structures. Slight modification of structure
could introduce sufficient steric interference to prevent the closeness of association
of adjacent membranes required to ensure adhesion. Insertion of an incorrect
amino acid in the peptide chains of cell membrane proteins or of an incorrect
sugar in a lipopolysaccharide might be sufficient modification to do so and could
result from alteration or substitution of a single base pair in the gene concerned.
It is plausible that the perfect " fit" postulated for normal membranes may serve
to exclude circulating large molecules which influence cell division-normal tissue
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cells can divide freely to repair damaged areas when membrane associations are
ruptured. Alternatively, it may ensure the retention of internally generated
large molecules which serve to repress division in normal cells.
This article has primarily been concerned with alterations in the control of
cell division by chemically induced mutations in the genes concerned. Probably
there are many such genes so that the types of tumours arising from chemical
carcinogenesis will differ with the different gene mutations, since chemical muta-
gens are not gene-specific. Other mechanisms which render genes inactive would
similarly interfere with their normal controlling function. One such may be their
specific complexing with other nucleic acids as, for example, with the whole or
part of the genome of an oncogenic virus, through complementarity of the base
sequences in the two structures. The requirement for complementarity would
restrict complex formation to a particular gene, or larger chromosome region, and
lead to the general similarity of viral induced tumours of a particular tissue, in
contrast to the variety found with chemically induced tumours. The affinity
of the viral genome, or part of it, for specific regions of a host cell chromosome
would greatly increase the frequency with which two homologous genes of a
diploid cell were simultaneously rendered inoperative so that, as observed, one
would expect early expression of viral induced carcinogenesis.
I have little doubt that the views expressed in this article are over-simplifi-
cations and that examples in apparent contradiction to them will readily come to
mind. Let us howeverattempt to account for generalities beforetrying to accom-
modate exceptions which are possibly serving to confuse. One is encouraged to
believe that, like so many problems in biology which until simply explained
appeared beyond hope ofresolution, the problem ofcarcinogenesis may also prove
explicable in simple terms.
SUMMARY
The foregoing proposal is submitted in explanation of the mechanism under-
lying chemical carcinogenesis. As a first event the initiator induces rare recessive
mutations in any of the probably numerous genes which collectively control the
regulation of normal cell division. In diploid mammalian cells the mutations
would remain unexpressed and the cells harbouring them could persist indefinitely
and unrecognisably in the tissue in which they arose. If later a second chemical
(the promoter) having the effect of allowing the mutant genes to become homo-
zygous was applied to the tissue, their mutant activity would be expressed to
give cells with altered regulation of division resulting in neoplasia. Mechanisms
which could lead to homozygosity are discussed. Misdivision, to give duplication
of a chromosome bearing a mutant gene and exclusion of its normal homologue,
would allow expression of all recessive characters determined by the duplicate
thereby permitting the neoplastic cells to show new properties, in addition to
altered regulation of division, which formerly were masked in the heterozygous
diploidprogenitor cells. Oncogenic viruses may similarly affect growth regulating
genes by specifically complexing with them or with regions of chromosome in
which they are included. A specificity determined by base sequence complemen-
tarity ofviral and host DNA could result in inactivation ofboth of a pair of alleles
with high frequency and so permit the early expression of virus induced tumours.
These would be expected to show a general similarity in contrast to the diversity
of tumour types arising from chemical carcinogenesis.
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